Artal Group S.A. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 90 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.99 and the average weighting 1.2%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$2,726,000
-49.2%
100,000
-50.0%
0.11%
-49.8%
Q2 2019$5,370,000
-53.6%
200,000
-50.0%
0.22%
-54.0%
Q1 2019$11,564,000
+7.4%
400,0000.0%0.47%
+18.3%
Q4 2018$10,772,000400,0000.40%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders